๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Extended Lamivudine Therapy against Hepatitis B Virus Infection in Hematopoietic Stem Cell Transplant Recipients

โœ Scribed by Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jin-Hwang Liu; Chiau-Jun Chu; Yu-Chen Lin; Ta-Chung Chao; Wei-Shu Wang; Chueh-Chuan Yen; Muh-Hwa Yang; Cheng-Hwai Tzeng; Po-Min Chen

Book ID
116278407
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
267 KB
Volume
12
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Lamivudine therapy for acute hepatitis B
Lamivudine therapy for acute hepatitis B infection following peripheral blood stem cell transplantation
โœ Rauf Haznedar; Mรผnci YaฤŸcฤฑ ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 166 KB ๐Ÿ‘ 2 views

Letters and correspondence submitted for possible publication must be identiยฎed as such. Text length must not exceed 500 words and ยฎve bibliographic references. A single concise ยฎgure or table may be included if it is essential to support the communication. Letters not typed double-spaced will not b

Lamivudine prophylaxis and treatment of
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab
โœ S.E. Moses; Z.Y. Lim; M. Sudhanva; S. Devereux; A.Y.L. Ho; A. Pagliuca; M. Zucke ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

Individuals with past exposure to hepatitis B virus (HBV) may reactivate HBV following bone marrow transplantation. Alemtuzumab (CAMPATH)based reduced intensity conditioning bone marrow transplantation has been associated with a high incidence of viral infections. Lamivudine prophylaxis for HBV shou